JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M004673200 on July 19, 2000

J. Biol. Chem., Vol. 275, Issue 42, 32598-32602, October 20, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/42/32598    most recent
M004673200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taguchi, T.
Right arrow Articles by Taniguchi, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taguchi, T.
Right arrow Articles by Taniguchi, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Purification and Characterization of UDP-GlcNAc: GlcNAcbeta 1-6(GlcNAcbeta 1-2)Manalpha 1-R [GlcNAc to Man]-beta 1, 4-N-acetylglucosaminyltransferase VI from Hen Oviduct*

Tomohiko TaguchiDagger §, Tomoya OgawaDagger , Sadako Inoue||, Yasuo Inoue||, Yoshihiro Sakamoto§, Hiroaki Korekane§, and Naoyuki Taniguchi§**

From Dagger  RIKEN (Institute of Physical and Chemical Research), Wako, Saitama 351-0198, Japan, the § Department of Biochemistry, Osaka University Medical School, Suita, Osaka 565-0871, Japan, and the || Institute of Biological Chemistry, Academia Sinica, Taipei 115, Taiwan

Received for publication, May 30, 2000, and in revised form, July 19, 2000


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A new beta 1,4-N-acetylglucosaminyltransferase (GnT) responsible for the formation of branched N-linked complex-type sugar chains has been purified 64,000-fold in 16% yield from a homogenate of hen oviduct by column chromatography procedures using Q-Sepharose FF, Ni2+-chelating Sepharose FF, and UDP-hexanolamine-agarose. This enzyme catalyzes the transfer of GlcNAc from UDP-GlcNAc to tetraantennary oligosaccharide and produces pentaantennary oligosaccharide with the beta 1-4-linked GlcNAc residue on the Manalpha 1-6 arm. It requires a divalent cation such as Mn2+ and has an apparent molecular weight of 72,000 under nonreducing conditions. The enzyme does not act on biantennary oligosaccharide (GnT I and II product), and beta 1,6-N-acetylglucosaminylation of the Manalpha 1-6 arm (GnT V product) is essential for its activity. This clearly distinguishes it from GnT IV, which is known to generate a beta 1-4-linked GlcNAc residue only on the Manalpha 1-3 arm. Based on these findings, we conclude that this enzyme is UDP-GlcNAc:GlcNAcbeta 1-6(GlcNAcbeta 1-2)Manalpha 1-R [GlcNAc to Man]-beta 1,4-N-acetylglucosaminyltransferase VI. This is the only known enzyme that has not been previously purified among GnTs responsible for antenna formation on the cores of N-linked complex-type sugar chains.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

To obtain insights into the functions of the N-linked glycans, it is essential to purify and to clone the enzymes responsible for their biosynthesis. Six different N-acetylglucosaminyltransferases (GnTs),1 I-VI, are known to be mainly involved in the branch formation on the cores of N-linked complex-type sugar chains. These enzymes are named as shown in Fig. 1 (1). GnT VI activity is defined as that catalyzing the transfer of GlcNAc to the Manalpha 1-6 arm and forms GlcNAcbeta 1-4Manalpha 1-6 linkage. Examples of the most highly branched N-linked complex-type glycan, which is a pentaantennary glycan with a bisecting GlcNAc residue, were found in hen ovomucoid (2, 3) and in the fish egg glycoprotein known as hyosophorin (4). GnTs I-V have been purified, and the corresponding genes have been cloned (5-19). Only GnT VI has not been purified, and its gene structure remains unknown.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 1.   GlcNAc-transferases (GnTs I-VI) involved in antenna formation on the cores of N-linked complex-type sugar chains.

This study reports the purification of GnT VI from hen oviduct, which has been previously shown to have high activity (20). By successive column chromatographies using Q-Sepharose FF, Ni2+-chelating Sepharose FF, and UDP-hexanolamine-agarose with a newly developed assay method (21) wherein pyridylaminated agalactotetraantennary oligosaccharide ([(2,4),(2,6)]-PA) (see Fig. 2) was used as an acceptor substrate and the reaction product was pyridylaminated agalactopentaantennary oligosaccharide ([(2,4),(2,4,6)]-PA) (see Fig. 2), this enzyme was purified 64,000-fold from a homogenate of hen oviduct. Using several acceptor compounds, the purified enzyme was shown to have an absolute requirement of GlcNAcbeta 1-2(GlcNAcbeta 1-6)Manalpha 1-R substrate sequence. The GnT VI enzyme is distinct from GnT IV, which generates a beta 1-4-linked GlcNAc residue only on the Manalpha 1-3 arm (13).

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- All materials were obtained from the following suppliers: UDP-GlcNAc, UDP-hexanolamine-agarose (ligand concentration of 2.4 µmol/ml), and GlcNAc from Sigma; Q-Sepharose FF and chelating Sepharose FF from Amersham Pharmacia Biotech (Uppsala, Sweden); Tris, HEPES, MES, and MOPS from Nacalai Tesque (Kyoto, Japan); Triton X-100, (p-amidinophenyl)methanesulfonyl fluoride hydrochloride, glycine, DTT, and metal chlorides from Wako (Osaka, Japan); [(2, 4),2]-PA from Takara Co. (Kyoto); and hen oviduct from Benchyo (Osaka).

Determination of GnT VI Activity-- GnT VI activity was assayed as described previously (21) with minor modifications. The standard incubation mixture contained the following components in a total volume of 10 µl: 150 mM HEPES (pH 8.0), 10 mM UDP-GlcNAc, 100 mM GlcNAc, 30 mM MnCl2, 0.5% Triton X-100, 2 mg/ml bovine serum albumin, 24 or 120 pmol of substrate ([(2,4),(2,6)]-PA), and 2 µl of enzyme fraction. After incubation at 37 °C for 4 h, 40 µl of water was added, and the enzyme reaction was stopped by boiling for 1 min. After centrifugation at 13,000 rpm for 5 min, 10 µl of the supernatant from the reaction mixture was applied to a TSK-Gel ODS-80TM column (4.6 × 75 mm; Tosoh, Tokyo, Japan). Elution was performed at 55 °C with 20 mM ammonium acetate (pH 4.0) at a flow rate of 1.6 ml/min. Fluorescence was monitored with excitation and emission wavelengths of 320 and 400 nm, respectively. The specific activity of the enzyme is expressed as picomoles of product formed per h/mg of protein. The protein concentration was determined with a BCA kit (Pierce) or a Bio-Rad protein assay kit using bovine serum albumin as the standard. The activities of GnTs III-V were measured according to the method of Nishikawa et al. (22).

Preparation of Oligosaccharides-- The structures of all oligosaccharides used in this assay are shown in Fig. 2. [(2,4),(2,6)]-PA was prepared from human alpha 1-acid glycoprotein essentially as described previously (21). [2,2]-PA for assay of GnTs III-V was prepared essentially as described previously (22). [2,(2,6)]-PA oligosaccharide was prepared from [2,2]-PA by reaction with UDP-GlcNAc, catalyzed by GnT V derived from the culture medium of QG cells (17). All of these structures were confirmed by methylation analysis and mass spectrometry.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 2.   Structures and abbreviations for pyridylaminated sugar chains used in this study. The numbers in brackets show the positions of the two alpha -Man residues to which nonreducing terminal GlcNAc residues are linked. The first set of parentheses indicate GlcNAc residues linked to the alpha -Man residue (Man-4) that is linked to the beta -Man residue by 1-3 linkage, and the second set of parentheses indicate GlcNAc residues linked to the alpha -Man residue (Man-4') that is linked to the beta -Man residue by 1-6 linkage. For example, [(2,4),(2,6)]-PA indicates the structure in which two GlcNAc residues are linked to Man-4 by beta 1-2 and beta 1-4 linkages and two GlcNAc residues are linked to Man-4' by beta 1-2 and beta 1-6 linkages.

Buffers Used in Purification of GnT VI-- The buffers used in this study were as follows: Buffer A, 0.25 M sucrose, 20 µM (p-amidinophenyl)methanesulfonyl fluoride hydrochloride, and 10 mM Tris-HCl (pH 7.5); Buffer B, 20% glycerol, 20 µM (p-amidinophenyl)methanesulfonyl fluoride hydrochloride, 1% Triton X-100, and 10 mM Tris-HCl (pH 7.5); Buffer C, 20% glycerol, 0.1% Triton X-100, and 10 mM Tris-HCl (pH 8.4); Buffer D, 20% glycerol, 0.4 M NaCl, 0.1% Triton X-100, and 20 mM Tris-HCl (pH 8.0); Buffer E, 20% glycerol, 0.05% Triton X-100, 10 mM MnCl2, 1 mM DTT, and 20 mM MOPS (pH 7.4); Buffer F, 20% glycerol, 0.05% Triton X-100, 1 mM DTT, 0.05 M NaCl, and 20 mM MOPS (pH 7.4); and Buffer G, 20% glycerol, 0.05% Triton X-100, 20 mM MnCl2, 1 mM DTT, and 20 mM MOPS (pH 7.4). pH measurements were performed at 4 °C.

Homogenization and Preparation of the Microsomal Fraction (Step 1)-- All purification steps were carried out at 4 °C. Frozen hen oviduct (270 g) was homogenized in a Waring Blendor in Buffer A. After centrifugation at 8000 rpm for 10 min, the supernatant was pooled, and the pellet was subjected to two more extractions, after which all the supernatants (1200 ml) were combined. Following centrifugation at 78,000 × g for 2 h, a microsomal fraction of ~13 g was obtained.

Solubilization of GnT VI (Step 2)-- The microsomal fraction was suspended in 150 ml of Buffer B, gently stirred for 2 h, and then centrifuged at 105,000 × g for 1 h. The supernatant fraction was collected, and the residual pellet was subjected to another extraction, followed by the same ultracentrifugation. The first and second Triton X-100 extracts were combined and used for further enzyme purification.

Q-Sepharose FF Column Chromatography (Step 3)-- The Triton X-100 extracts were applied to a column of Q-Sepharose FF (10 × 4 cm) that had been equilibrated with Buffer C. Fractions of 40 ml were collected through this column chromatography. The column was washed with Buffer C until the protein concentration was reduced to 1.0 mg/ml. Elution was then carried out with a linear gradient established between 1000 ml of Buffer C and 1000 ml of 0.8 M NaCl/Buffer C. The fractions containing GnT VI activity were combined.

Ni2+-chelating Sepharose FF Column Chromatography (Step 4)-- The pool of fractions from Step 3 was applied directly to a column of Ni2+-chelating Sepharose FF (2.5 × 10 cm) that had been equilibrated with Buffer D. Ni2+-chelating Sepharose FF resin was layered on the chelating Sepharose FF resin without metal ions (2.5 × 5 cm) to avoid any possible leakage of Ni2+. Fractions of 11 ml were collected through this column chromatography. All of the GnT VI activity was retained by the column. After washing the column with Buffer D until the protein concentration was reduced to 0.2 mg/ml, GnT VI activity was eluted with a linear gradient established between 300 ml of Buffer D and 300 ml of 0.1 M glycine/Buffer D. The fractions containing GnT VI activity were combined, and the buffer in this fraction was replaced by Buffer E by means of an Amicon Diaflow Ultrafiltrater using a YM-30 membrane (Amicon, Inc., Beverly, MA).

UDP-hexanolamine-Agarose Affinity Column Chromatography (Step 5)-- After the above step, the column was siliconized with Sigmacote (Sigma), and siliconized tubes (Assist, Tokyo) were used for fractionation. The UDP-hexanolamine-agarose column (1.5 × 15 cm) had been equilibrated with 0.05 M NaCl/Buffer E, and the concentrated enzyme fraction from Step 4 was applied to the column, followed by washing with 100 ml of Buffer E. GnT VI activity was eluted with Buffer F. At the loading and washing steps, fractions of 5 ml were collected. At the elution step, fractions of 1.4 ml were collected, and those containing GnT VI activity were pooled.

UDP-hexanolamine-Agarose Affinity Column Chromatography (Step 6)-- An equal volume of Buffer G was added to the pool of fractions from Step 5, and this solution was rechromatographed by the same procedure as described for Step 5. This purified GnT VI fraction was used for the enzyme characterization.

Gel Electrophoresis-- SDS-polyacrylamide gel electrophoresis was performed by the method of Laemmli (23) using 10% gels. Molecular markers (Amersham Pharmacia Biotech, Little Chalfont, United Kingdom) were used for size standards. Proteins on the gels were stained with a silver staining kit (DAIICHI 2D silver stain II, Daiichi Pure Chemicals, Tokyo).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Purification of GnT VI-- The activity of GnT VI was assayed using the fluorescently labeled agalactotetraantennary sugar chain as an acceptor substrate basically according to the original method of Taguchi et al. (21). Since bovine serum albumin (2 mg/ml) was found to be effective in preserving enzyme activity at 37 °C, especially for the highly purified enzyme fraction (Steps 5 and 6), it was routinely included in the standard assay mixture.

Like other glycosyltransferases, GnT VI activity was found in the microsomal fraction. At least 80% of the GnT VI activity was associated with the microsomal fraction. GnT VI activity was successfully solubilized from the microsomal fraction by extraction with Triton X-100. Substantial amounts of proteins were separated from GnT VI by Q-Sepharose FF and Ni2+-chelating Sepharose FF chromatographies (Fig. 3, A and B). After the Ni2+-chelating Sepharose FF column chromatography (Step 4), the enzyme was more stable than in Steps 2 and 3. As opposed to results with GnTs III and IV (11, 13), no GnT VI activity was eluted after application to a Cu2+-chelating column. Following the above two column chromatography steps, the GnT VI active fraction still contained GnT III and beta 1,4-galactosyltransferase activities. Cation exchange, dye affinity, gel filtration, and lectin column chromatographies did not prove to be effective for further purification of the enzyme fraction after Step 4. The use of an affinity column (Steps 5 and 6) (Fig. 3C) packed with an analog of the common donor substrate for GnTs (UDP-hexanolamine) as a ligand was effective. This affinity column has been proven to be very effective for purification of GnTs and was first used for the purification of GnT I by Oppenheimer and Hill (5). The activity of GnT III was not bound to this column under the conditions described under "Experimental Procedures." The majority of GnT VI activity was bound to this affinity column and was eluted by the buffer lacking MnCl2. Since the eluted fraction (after Step 5) still contained several proteins as revealed by SDS-polyacrylamide gel electrophoresis (data not shown), this fraction was rechromatographed (Step 6) under the same conditions as described for Step 5. The addition of DTT was crucial in preserving GnT VI activity after Steps 5 and 6, whereas it was without effect in Step 4. The enzyme fraction of Step 6 showed a single broad band with a molecular weight of 72,000 on SDS-polyacrylamide gel electrophoresis under nonreducing conditions (Fig. 4) and of 60,000 under reducing conditions (data not shown), suggesting that the enzyme was a glycoprotein. This band was also correlated with GnT VI activity by elution with UDP (5 mM) or NaCl (0.4 M) from a UDP-hexanolamine-agarose column, suggesting that this band was GnT VI (data not shown). No GnT III-V activities were detected in this fraction when [2,2]-PA was used as an acceptor substrate. All experiments for enzyme characterization described below were performed using the chromatographic Step 6 material. Table I summarizes the purification of GnT VI, which was purified 64,000-fold in 16% yield.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 3.   Chromatographic elution patterns obtained in the purification of GnT VI. A, Q-Sepharose FF column chromatography (Step 3); B, Ni2+-chelating Sepharose FF column chromatography (Step 4); C, UDP-hexanolamine-agarose column chromatography (Step 5). Fractions indicated by bars were pooled.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 4.   SDS-polyacrylamide gel electrophoresis of GnT VI. A purified GnT VI fraction (after Step 6) was analyzed on a 10% SDS-polyacrylamide gel under nonreducing conditions and stained with silver. The position of GnT VI is indicated by the arrow. K indicates molecular weight in thousands.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Purification of GnT VI from hen oviduct

pH Optimum-- GnT VI possessed activity over a relatively broad pH range with an optimum at pH 7.75.

Effect of MnCl2 Concentration on GnT VI Activity-- GnT VI activity was Mn2+-dependent and was high around 5 mM. When the MnCl2 concentration was increased, the activity gradually decreased.

Effect of Divalent Cations on GnT VI Activity-- The effects of divalent cations on GnT VI activity were examined. The activity was maximal with Mn2+. Co2+, Mg2+, and Ni2+ could partially substitute for Mn2+, whereas Ca2+, Zn2+, Fe2+, and Cu2+ showed no significant effect (Table II).

                              
View this table:
[in this window]
[in a new window]
 
Table II
Effects of metal ions on GnT VI activity
Each metal ion (10 mM) was added as the chloride salt. GnT VI activity in the presence of 10 mM MnCl2 is taken as 100%. ND, not detected.

Acceptor Substrate Specificity-- The acceptor substrate specificity of GnT VI was examined using complex-type sugar chains. Purified GnT VI was revealed to select its substrate clearly (Table III). It could transfer GlcNAc to [(2,4),(2,6)]-PA and [2,(2, 6)]-PA (GnT V product), whereas no activity was observed when [2,2]-PA or [(2,4),2]-PA (GnT IV product) was used as a substrate.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Substrate specificity of GnT VI
GnT VI activity was assayed as described under "Experimental Procedures" at substrate levels of 12 µM. GnT VI activity in the presence of [(2,4),(2,6)]-PA as an acceptor is taken as 100%. 100% enzyme activity corresponds to 4.7 nmol/h/ml. The structures of the acceptor sugar chains are shown in Fig. 2. ND, not detected.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Six different GnTs (I-VI) are known to be mainly involved in antenna formation on the cores of N-linked complex-type sugar chains (Fig. 1). In addition, Raju and Stanley (24) recently identified two other distinct GnT activities designated GnTs VII and VIII from Chinese hamster ovary mutant cells. GnT VI activity is defined as that catalyzing the transfer of GlcNAc to the Manalpha 1-6 arm and forms a GlcNAcbeta 1-4Manalpha 1-6 linkage. Only GnT VI has not been purified in the GnTs that act on alpha -Man residues. The substrate specificity of GnT VI has not been clearly determined, although it has been suggested, by using hen oviduct microsomes as an enzyme source, that GnT VI acts after assembly of GlcNAcbeta 1-2Manalpha 1-3-, GlcNAcbeta 1-2Manalpha 1-6-, and GlcNAcbeta 1-6Manalpha 1-6- antennae by the action of GnTs I, II, and V, respectively (20). The tissue distribution of this enzyme seems to be highly restricted. So far, only avian oviduct (20) and fish ovary (25) have been shown to express this enzyme activity. The transferrin synthesized by the human hepatocarcinoma cell line HepG2 was reported to have a pentaantennary glycan chain (26), which is the product of GnT VI activity.

In this study, we have purified GnT VI from hen oviduct 64,000-fold with a newly developed assay method (21) wherein [(2,4),(2,6)]-PA (Fig. 2) was used as an acceptor substrate, and the reaction product was [(2,4),(2,4,6)]-PA (Fig. 2). Cloning of this GnT VI gene is now in progress based on the peptide sequences obtained from the purified enzyme. The specificity of this purified GnT VI is summarized as follows (see Table III). (a) no GnT III and IV activities were observed, both of which can act on [2,2]-PA and produce GlcNAcbeta 1-4 linkages on the beta -linked Man residue and the Manalpha 1-3 residue, respectively (11, 13). (b) GnT VI activity was observed when [(2,4),(2,6)]-PA and [2,(2,6)]-PA were used as acceptor substrates. (c) GnT VI activity was not detected when [(2,4),2]-PA was used as a substrate. From these observations, it is concluded that beta 1,6-N-acetylglucosaminylation to the Manalpha 1-6 arm (GnT V product) is essential for its activity. This defines GnT VI activity as UDP-GlcNAc:GlcNAcbeta 1-6(GlcNAcbeta 1-2)Manalpha 1-R [GlcNAc to Man]-beta 1,4-N-acetylglucosaminyltransferase. This characteristic clearly distinguishes this enzyme from GnT IV, which is known to generate a beta 1-4-linked GlcNAc residue only on the Manalpha 1-3 arm (13). In addition, it should be pointed out that this purified GnT VI does not have GnT VI' activity, which is defined as that making GlcNAcbeta 1-2(GlcNAcbeta 1-4)Manalpha 1-6 linkage without the requirement of a GlcNAcbeta 1-6Manalpha 1-6 structure (27), since no product was detected when [2,2]-PA was used as a substrate. In conjunction with previous observations, the biosynthetic pathways leading to a bisected pentaantennary glycan chain are depicted in Fig. 5.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 5.   Biosynthetic pathways leading to a bisected pentaantennary N-glycan. Gn, GlcNAc; M, Man.

The substrate specificity of purified GnT VI agrees with the results reported by Brockhausen et al. (20) in a study using hen oviduct microsomes as the enzyme source and GlcNAcbeta 1-6(GlcNAcbeta 1-2)Manalpha 1-6Manbeta 1-(CH2)8COOCH3 as an acceptor substrate. Some differences from their results in terms of optimal conditions for activity, e.g. the effect of Mn2+ concentration and the effects of divalent cations, are to be noted. Differences are also noted for the optimal conditions of enzyme from hen oviduct microsomes (21) and this purified GnT VI using the same substrate, [(2,4),(2,6)]-PA. Such discrepancies could be due to the presence of another (or other) GnT VI(s) in hen oviduct microsomes.

    ACKNOWLEDGEMENT

We thank Dr. Harold F. Deutsch (University of Wisconsin Medical School, Madison, WI) for editing this manuscript.

    FOOTNOTES

* This work was supported by a postdoctoral fellowship from RIKEN (to T. T.) and by Grant-in-aid for Scientific Research on Priority Areas 10178104 from the Ministry of Education, Science, Sports, and Culture of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Present address: Dept. of Cell Biology, Yale University School of Medicine, New Haven, CT 06520-8002.

** To whom correspondence should be addressed. Tel.: 81-6-6879-3420; Fax: 81-6-6879-3429; E-mail: proftani@biochem.med.osaka-u.ac.jp.

Published, JBC Papers in Press, July 19, 2000, DOI 10.1074/jbc.M004673200

    ABBREVIATIONS

The abbreviations used are: GnTs, N-acetylglucosaminyltransferases; PA, 2-aminopyridine; MES, 2-(N-morpholino)ethanesulfonic acid; MOPS, 3-(N-morpholino)propanesulfonic acid; DTT, dithiothreitol.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Schachter, H. (1991) Glycobiology 1, 453-461
2. Yamashita, K., Kamerling, J. P., and Kobata, A. (1982) J. Biol. Chem. 257, 12809-12814
3. Parente, J. P., Wieruszeski, J.-M., Strecker, G., Montreuil, J., Fournet, B., van Halbeek, H., Dorland, L., and Vliegenthart, J. F. G. (1982) J. Biol. Chem. 257, 13173-13176
4. Inoue, S., and Inoue, Y. (1997) in Glycoproteins II (Montreuil, J. , Vliegenthart, J. F. G. , and Schachter, H., eds) , pp. 143-161, Elsevier Science Publishing Co., Inc., New York
5. Oppenheimer, C. L., and Hill, R. L. (1981) J. Biol. Chem. 256, 799-804
6. Nishikawa, Y., Pegg, W., Paulsen, H., and Schachter, H. (1988) J. Biol. Chem. 263, 8270-8281
7. Kumar, R., Yang, J., Larsen, R. D., and Stanley, P. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 9948-9952
8. Sarkar, M., Hull, E., Nishikawa, Y., Simpson, R. J., Moritz, R. L., Dunn, R., and Schachter, H. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 234-238
9. Bendiak, B., and Schachter, H. (1987) J. Biol. Chem. 262, 5775-5783
10. D'Agostaro, G. A. F., Zingoni, A., Moritz, R. L., Simpson, R. J., Schachter, H., and Bendiak, B. (1995) J. Biol. Chem. 270, 15211-15221
11. Nishikawa, A., Ihara, Y., Hatakeyama, M., Kangawa, K., and Taniguchi, N. (1992) J. Biol. Chem. 267, 18199-18204
12. Ihara, Y., Nishikawa, A., Tohma, T., Soejima, H., Niikawa, N., and Taniguchi, N. (1993) J. Biochem. (Tokyo) 113, 692-698
13. Oguri, S., Minowa, M. T., Ihara, Y., Taniguchi, N., Ikenaga, H., and Takeuchi, M. (1997) J. Biol. Chem. 272, 22721-22727
14. Minowa, M. T., Oguri, S., Yoshida, A., Hara, T., Iwamatsu, A., Ikenaga, H., and Takeuchi, M. (1998) J. Biol. Chem. 273, 11556-11562
15. Yoshida, A., Minowa, M. T., Takamatsu, S., Hara, T., Oguri, S., Ikenaga, H., and Takeuchi, M. (1999) Glycobiology 9, 303-310
16. Shoreibah, M. G., Hindsgaul, O., and Pierce, M. (1992) J. Biol. Chem. 267, 2920-2927
17. Gu, J., Nishikawa, A., Tsuruoka, N., Ohno, M., Yamaguchi, N., Kangawa, K., and Taniguchi, N. (1993) J. Biochem. (Tokyo) 113, 614-619
18. Shoreibah, M., Perng, G.-S., Adler, B., Weinstein, J., Basu, R., Cupples, R., Wen, D., Browne, J. K., Buckhaults, P., Fregien, N., and Pierce, M. (1993) J. Biol. Chem. 268, 15381-15385
19. Saito, H., Nishikawa, A., Gu, J., Ihara, Y., Soejima, H., Wada, Y., Sekiya, C., Niikawa, N., and Taniguchi, N. (1994) Biochem. Biophys. Res. Commun. 198, 318-327
20. Brockhausen, I., Hull, E., Hindsgaul, O., Schachter, H., Shah, R. N., Michnick, S. W., and Carver, J. P. (1989) J. Biol. Chem. 264, 11211-11221
21. Taguchi, T., Ogawa, T., Kitajima, K., Inoue, S., Inoue, Y., Ihara, Y., Sakamoto, Y., Nagai, K., and Taniguchi, N. (1998) Anal. Biochem. 255, 155-157
22. Nishikawa, A., Gu, J., Fujii, S., and Taniguchi, N. (1990) Biochim. Biophys. Acta 1035, 313-318
23. Laemmli, U. K. (1970) Nature 227, 680-685
24. Raju, T. S., and Stanley, P. (1998) J. Biol. Chem. 273, 14090-14098
25. Taguchi, T., Kitajima, K., Inoue, S., Inoue, Y., Yang, J.-M., Schachter, H., and Brockhausen, I. (1997) Biochem. Biophys. Res. Commun. 230, 533-536
26. Campion, B., Léger, D., Wieruszeski, J.-M., Montreuil, J., and Spik, G. (1989) Eur. J. Biochem. 184, 405-413
27. Brockhausen, I., Möller, G., Yang, J.-M., Khan, S. H., Matta, K. L., Paulsen, H., Grey, A. A., Shah, R. N., and Schachter, H. (1992) Carbohydr. Res. 236, 281-299


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GlycobiologyHome page
T. Watanabe, H. Ihara, E. Miyoshi, K. Honke, N. Taniguchi, and T. Taguchi
A specific detection of GlcNAc{beta}1-6Man{alpha}1 branches in N-linked glycoproteins based on the specificity of N-acetylglucosaminyltransferase VI
Glycobiology, May 1, 2006; 16(5): 431 - 439.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
H. Korekane, T. Taguchi, Y. Sakamoto, K. Honke, N. Dohmae, H. Salminen, S. Toivonen, J. Helin, K. Takio, O. Renkonen, et al.
Purification and cDNA cloning of UDP-GlcNAc:GlcNAc{beta}1-3Gal{beta}1-4Glc(NAc)-R [GlcNAc to Gal]{beta}1,6N-acetylglucosaminyltransferase from rat small intestine: a major carrier of dIGnT activity in rat small intestine
Glycobiology, May 1, 2003; 13(5): 387 - 400.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
K. Sasai, Y. Ikeda, T. Fujii, T. Tsuda, and N. Taniguchi
UDP-GlcNAc concentration is an important factor in the biosynthesis of {beta}1,6-branched oligosaccharides: regulation based on the kinetic properties of N-acetylglucosaminyltransferase V
Glycobiology, February 1, 2002; 12(2): 119 - 127.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Sakamoto, T. Taguchi, K. Honke, H. Korekane, H. Watanabe, Y. Tano, N. Dohmae, K. Takio, A. Horii, and N. Taniguchi
Molecular Cloning and Expression of cDNA Encoding Chicken UDP-N-acetyl-D-glucosamine (GlcNAc): GlcNAcbeta 1-6(GlcNAcbeta 1-2)- Manalpha 1-R[GlcNAc to Man]beta 1,4N-acetylglucosaminyltransferase VI
J. Biol. Chem., November 10, 2000; 275(46): 36029 - 36034.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/42/32598    most recent
M004673200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taguchi, T.
Right arrow Articles by Taniguchi, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taguchi, T.
Right arrow Articles by Taniguchi, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.